ODF2L and ovarian carcinoma: Moreover, data mined from the Cancer Therapeutics Response Portal (CTRP), a database reporting correlations between gene expression and drug resistance for over 800 cancer cell lines, showed that ODF2L expression most significantly positively correlated with resistance to AZD1775 in ovarian cancer (Figure 1C).